Sun Y-S, Zhao Z, Yang Z-N, Xu F, Lu H-J, Zhu Z-Y, Shi W, Jiang J, Yao P-P, Zhu H-P. Risk factors and preventions of breast cancer. Int J Biol Sci. 2017. https://doi.org/10.7150/ijbs.21635.

Article  PubMed  PubMed Central  Google Scholar 

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021. https://doi.org/10.3322/caac.21660.

Article  PubMed  Google Scholar 

Pan H, Gray R, Braybrooke J, Davies C, Taylor C, McGale P, Peto R, Pritchard KI, Bergh J, Dowsett M, et al. 20-Year risks of breast-cancer recurrence after stopping endocrine therapy at 5 years. N Engl J Med. 2017. https://doi.org/10.1056/NEJMoa1701830.

Article  PubMed  PubMed Central  Google Scholar 

Zhang X. Molecular classification of breast cancer: relevance and challenges. Arch Pathol Lab Med. 2023. https://doi.org/10.5858/arpa.2022-0070-RA.

Article  PubMed  Google Scholar 

Li A, Zheng X, Liu D, Huang R, Ge H, Cheng L, Zhang M, Cheng H. Physical activity and depression in breast cancer patients: mechanisms and therapeutic potential. Curr Oncol Tor Ont. 2025. https://doi.org/10.3390/curroncol32020077.

Article  Google Scholar 

Xu C, Ganesan K, Liu X, Ye Q, Cheung Y, Liu D, Zhong S, Chen J. Prognostic value of negative emotions on the incidence of breast cancer: a systematic review and meta-analysis of 129,621 patients with breast cancer. Cancers. 2022. https://doi.org/10.3390/cancers14030475.

Article  PubMed  PubMed Central  Google Scholar 

Kamen C, Scheiber C, Janelsins M, Jo B, Shen H, Palesh O. Effects of childhood trauma exposure and cortisol levels on cognitive functioning among breast cancer survivors. Child Abuse Negl. 2017. https://doi.org/10.1016/j.chiabu.2017.07.005.

Article  PubMed  PubMed Central  Google Scholar 

Li H, Marsland AL, Conley YP, Sereika SM, Bender CM. Genes involved in the HPA axis and the symptom cluster of fatigue, depressive symptoms, and anxiety in women with breast cancer during 18 months of adjuvant therapy. Biol Res Nurs. 2020. https://doi.org/10.1177/1099800419899727.

Article  PubMed  PubMed Central  Google Scholar 

Wang X, Wang N, Zhong L, Wang S, Zheng Y, Yang B, Zhang J, Lin Y, Wang Z. Prognostic value of depression and anxiety on breast cancer recurrence and mortality: a systematic review and meta-analysis of 282,203 patients. Mol Psychiatry. 2020. https://doi.org/10.1038/s41380-020-00865-6.

Article  PubMed  PubMed Central  Google Scholar 

Mustafa M, Carson-Stevens A, Gillespie D, Edwards AG. Psychological interventions for women with non-metastatic breast cancer. Cochrane Database Syst Rev. 2013. https://doi.org/10.1002/14651858.CD004253.pub4.

Article  PubMed  PubMed Central  Google Scholar 

Sun D, Zhu L, Zhao Y, Jiang Y, Chen L, Yu Y, Ouyang L. Fluoxetine induces autophagic cell death via eEF2K-AMPK-mTOR-ULK complex axis in triple negative breast cancer. Cell Prolif. 2018. https://doi.org/10.1111/cpr.12402.

Article  PubMed  PubMed Central  Google Scholar 

Cho Y-W, Kim E-J, Nyiramana MM, Shin E-J, Jin H, Ryu JH, Kang KR, Lee G-W, Kim HJ, Han J, et al. Paroxetine induces apoptosis of human breast cancer MCF-7 cells through Ca2+-and p38 MAP kinase-dependent ROS generation. Cancers. 2019. https://doi.org/10.3390/cancers11010064.

Article  PubMed  PubMed Central  Google Scholar 

Sagara A, Nakata K, Matsumoto S, Guan W, Shinkawa T, Iwamoto C, Ikenaga N, Ohuchida K, Nakamura M. Repositioning of duloxetine to target pancreatic stellate cells. Oncol Lett. 2021. https://doi.org/10.3892/ol.2021.13005.

Article  PubMed  PubMed Central  Google Scholar 

Miricescu D, Totan A, Stanescu-Spinu I-I, Badoiu SC, Stefani C, Greabu M. PI3K/AKT/mTOR signaling pathway in breast cancer: from molecular landscape to clinical aspects. Int J Mol Sci. 2020. https://doi.org/10.3390/ijms22010173.

Article  PubMed  PubMed Central  Google Scholar 

Zhu K, Wu Y, He P, Fan Y, Zhong X, Zheng H, Luo T. PI3K/AKT/mTOR-targeted therapy for breast cancer. Cells. 2022. https://doi.org/10.3390/cells11162508.

Article  PubMed  PubMed Central  Google Scholar 

Hinz N, Jücker M. Distinct functions of AKT isoforms in breast cancer: a comprehensive review. Cell Commun Signal. 2019. https://doi.org/10.1186/s12964-019-0450-3.

Article  PubMed  PubMed Central  Google Scholar 

Alves CL, Ditzel HJ. Drugging the PI3K/AKT/mTOR pathway in ER+ breast cancer. Int J Mol Sci. 2023. https://doi.org/10.3390/ijms24054522.

Article  PubMed  PubMed Central  Google Scholar 

Yuan Y, Long H, Zhou Z, Fu Y, Jiang B. PI3K-AKT-targeting breast cancer treatments: natural products and synthetic compounds. Biomolecules. 2023. https://doi.org/10.3390/biom13010093.

Article  PubMed  PubMed Central  Google Scholar 

Christensen SB. Drugs that changed society: microtubule-targeting agents belonging to taxanoids macrolides and non-ribosomal peptides. Molecules. 2022. https://doi.org/10.3390/molecules27175648.

Article  PubMed  PubMed Central  Google Scholar 

Kale PP, Addepalli V. Augmentation of antidepressant effects of duloxetine and bupropion by caffeine in mice. Pharmacol Biochem Behav. 2014. https://doi.org/10.1016/j.pbb.2014.06.005.

Article  PubMed  Google Scholar 

Cumashi A, Tinari N, Rossi C, Lattanzio R, Natoli C, Piantelli M, Iacobelli S. Sunitinib malate (SU-11248) alone or in combination with low-dose docetaxel inhibits the growth of DU-145 prostate cancer xenografts. Cancer Lett. 2008. https://doi.org/10.1016/j.canlet.2008.05.007.

Article  PubMed  Google Scholar 

Wang H, Guo S, Kim S-J, Shao F, Ho JWK, Wong KU, Miao Z, Hao D, Zhao M, Xu J, et al. Cisplatin prevents breast cancer metastasis through blocking early EMT and retards cancer growth together with paclitaxel. Theranostics. 2021. https://doi.org/10.7150/thno.46460.

Article  PubMed  PubMed Central  Google Scholar 

Malgaroli M, Szuhany KL, Riley G, Miron CD, Park JH, Rosenthal J, Chachoua A, Meyers M, Simon NM. Heterogeneity of posttraumatic stress, depression, and fear of cancer recurrence in breast cancer survivors: a latent class analysis. J Cancer Surviv Res Pract. 2023. https://doi.org/10.1007/s11764-022-01195-y.

Article  Google Scholar 

Berry A, Collacchi B, Capoccia S, D’Urso MT, Cecchetti S, Raggi C, Sestili P, Aricò E, Pontecorvi G, Puglisi R, et al. Chronic isolation stress affects central neuroendocrine signaling leading to a metabolically active microenvironment in a mouse model of breast cancer. Front Behav Neurosci. 2021. https://doi.org/10.3389/fnbeh.2021.660738.

Article  PubMed  PubMed Central  Google Scholar 

Adams JM, Cory S. The Bcl-2 protein family: arbiters of cell survival. Science. 1998. https://doi.org/10.1126/science.281.5381.1322.

Article  PubMed  Google Scholar 

Moawadh MS, Mir R, Tayeb FJ, Asim O, Ullah MF. Molecular evaluation of the impact of polymorphic variants in apoptotic (Bcl-2/Bax) and proinflammatory cytokine (TNF-α/IL-8) genes on the susceptibility and progression of myeloproliferative neoplasms: a case–control biomarker study. Curr Issues Mol Biol. 2023. https://doi.org/10.3390/cimb45050251.

Article  PubMed  PubMed Central  Google Scholar 

Hata AN, Engelman JA, Faber AC. The BCL2 family: key mediators of the apoptotic response to targeted anticancer therapeutics. Cancer Discov. 2015. https://doi.org/10.1158/2159-8290.CD-15-0011.

Article  PubMed  PubMed Central  Google Scholar 

Canales A, Rodríguez-Salarichs J, Trigili C, Nieto L, Coderch C, Andreu JM, Paterson I, Jiménez-Barbero J, Díaz JF. Insights into the interaction of discodermolide and docetaxel with tubulin. Mapping the binding sites of microtubule-stabilizing agents by using an integrated NMR and computational approach. ACS Chem Biol. 2011. https://doi.org/10.1021/cb200099u.

Article  PubMed  Google Scholar 

Wang TH, Wang HS, Soong YK. Paclitaxel-induced cell death: where the cell cycle and apoptosis come together. Cancer. 2000. https://doi.org/10.1002/1097-0142(20000601)88:11%3c2619::aid-cncr26%3e3.0.co;2-j.